The war between Israel and Hamas brings its own set of business challenges. Challenges that may impact how we communicate with partners and investors abroad. We should portray the life science sector as resilient and adaptable, even in times of crisis. This document is a a messaging outline for Israel's Life Science Hub despite the war with Hamas. Four key points to emphasize: 1) Global activity (resilience and agility) 2) Continuity of care and preventive medicine 3) World leading clinical trials industry 4) Dynamic scientific, research and entrepreneurial ecosystems

1. ISRAEL’S LIFE
SCIENCE HUB
#NOWMORETHANEVER
#NOMATTERWHAT
Messaging guide

2. ‫‏‬
30/11/2023
My Honorable Colleagues,
Re: Israel Life Science Hub - #nowmorethanever
I am proud to present an abstract of this messaging guide, on behalf of the
Health Council.
The messaging guide is part of a special initiative to help Israeli life science and
pharma professionals communicate effectively during crises. This guide
highlights Israel's strengths in four areas: global activities, treatment
coordination, clinical research, and science and innovation.
Amazing people came together and worked tirelessly to make this special
project a reality. You can find the list of initiative members and partners on page
10 of this guide. If you need more information or any assitance, feel free to
contact any of us.
I want to thank Mr. Asher Shalmon and my colleagues at the Ministry of Health
for his support in this project. A special thanks goes to Harella Halevy, who
skillfully initiated and wrote the full messaging guide and this abstract.
Together, we prevail!
Best regards,
Prof. Meir Pugatch
Chairman of the Monitoring and Research Committee, Health Council
-2-

3. The war between Israel and Hamas brings its own set of business
challenges. Challenges that may impact how we communicate with
partners and investors abroad. We should portray the life science sector
as resilient and adaptable, even in times of crisis.
The English version of the messaging guide is an abstract of the
document in Hebrew. While the Hebrew guide highlights
communication and storytelling principles, this abstract only includes
messaging and background about the four focus areas.
#NOWMORETHANEVER
-3-

4. General advantages of the life
science industry in Israel
It is advisable not to delve into the complex situation in Israel. We must find the facts
that show how Israel prevails during challenging times. In the past, crises have shown
that we can keep working even when times are tough.
Optional messages:
Israel triumphs over adversity, navigating political instabilities with
resilience. Our indomitable spirit ensures business as usual.
We know many of you have faith in Israel’s abilities and understand the
strength and resilience of the sector.
The Israeli health and scientific sectors have gained the trust of global
investment community and its customers throughout the years.
Israeli health management teams have always proved to be agile, no
matter what. Data shows...(add applicable)
Israel’s agility and speed in adapting to shifting situations have always
helped keep the health sector on track.
The highly resilient (medical/health/science) sector will not only survive
but thrive during this conflict, highlighting Israel's resilience amid
persistent challenges.
-4-

5. 1: Global activity
Amidst challenging times, the Israeli HealthTech industry stands resilient,
leveraging a powerful combination of robust health systems, cutting-edge
technology, exceptional human capital, and strong infrastructure.
Fueled by a unique culture of agility, resilience, and creativity, our industry
continues to deliver unwavering results for patients, partners, and products, no
matter what. In adversity, innovation thrives, making us a steadfast force in
healthcare solutions. International companies active in Israel adapt seamlessly,
delivering world-class services and products, advancing the pinnacle of care.
Agility:
Our commitment to agility and robust infrastructure ensures seamless
collaboration between the Ministry of Health, Health Maintenance
Organizations (HMOs), and Hospitals. This dynamic synergy guarantees
uninterrupted treatment continuity, providing a resilient foundation for
effective crisis response.
Resilience:
In times of challenge, our adaptability becomes a cornerstone, reinforcing our
dedication to delivering unwavering healthcare solutions. Our startup
leadership's commitment transcends challenges, ensuring steadfast delivery
for clients.
Optional messages:
Israel’s agile infrastructure ensures treatment continuity and a resilient
foundation to effectively respond to crisis.
International pharma companies in Israel adapt seamlessly, delivering
world-class services and products to one of the most advanced healthcare
systems in the world.
Adaptable resilience is the basis of our unwavering commitment:
Delivering healthcare solutions despite challenges, ensuring client
satisfaction.
-5-

6. Israel's visionary investment merges high-tech, cyber, and life sciences
—fueling growth and pioneering bio-convergence. Join innovation!
Pioneering research, global benchmarks. Our scholars drive knowledge
exchange, shaping quality standards in academia worldwide.
Innovation close at hand! Israel's health ecosystem bridges experts
effortlessly—shortening distances between research, industry, and global
collaborations.
Dive into innovation! Israel's dynamic landscape boasts entrepreneurs,
innovation centers, and global digital health leaders.
-6-

7. 2: Continuous care
Israel is renowned for its patient care, ensuring that even during crises and
wartime, patients can access services within their chosen HMO network
throughout the entire country. This approach promotes continuity of care
and a steadfast focus on preventive medicine.
Israel's Ministry of Health proactively adopts technology, streamlining
processes for efficient, patient-centered care. This has led advancements in
digital health records, telemedicine, and health information exchange.
During wartime, the Ministry of Health proactively collaborates with
pharmaceutical firms, simplifying regulatory processes for uninterrupted
medicine importation. Embracing innovation establishes Israel as a health
technology leader, enhancing healthcare delivery.
Israel is renowned for its resilience and innovation, it maintains an
unwavering commitment to medical research and technology, overcoming
any challenges it encounters.
Optional messages:
Make Israel's healthcare a top priority for investment. Renowned for
resilience and innovation, its unwavering commitment to medical
research thrives despite challenges.
Israel's patient-centric care is unwavering, providing patients continuous
access to care even in times of crises.
Israel‘s HMO network ensures uninterrupted services, emphasizing
preventive medicine and ensuring continuity of care.
-7-

8. 3: Clinical trials
Despite the heartbreaking consequences of the 7/10 atrocities, Israel’s life
science ecosystem remains resilient and reliable. Israel is known for efficient
regulatory processes, a diverse patient population, and a commitment to
integrating data and innovation. Clinical trials persist, prioritizing patient
recruitment and global leadership in research.
Companies that invest in Israel engage with the best in the field, have access
to extensive medical records, and are at the forefront of innovation.
Investing in clinical trials in Israel is an investment in the global healthcare
landscape of tomorrow. We call on MNC, startups, CROs and all other
partners in the global clinical trials landscape to choose Israel as your
preferred CT site – now, more than ever!
Optional messages:
Israel renowned world-class experts and it‘s advanced medical facilities
have long and successful track record of CT from First-in-human to
phase 3.
Israel has a unique scientific networked ecosy
stem. Enterprising
physicians collaborate closely with top scientists and industry,
integrating data to pioneer novel technologies and tools tailored for
clinical trials
Decades of medical data, proactive regulators, and a culture of
innovation led by entrepreneurial physicians makes Israel one of the top
locations to invest in CTs.
-or-
Investing in clinical trials in Israel ensures world-class experts,
unparalleled access to over 30 years‘ of comprehensive medical data,
and a collaborative environment driving innovation.
-8-

9. 4: Science and Innovation
The Israeli scientific ecosystem has flourished over the years and holds a pivotal
position in bringing the world innovative technological solutions in numerous
fields, and will continue to do so in the future. In late 2022 and 2023 (before the
war broke out) we witnessed a slowdown in investments in startups that
corresponded with global trends, with added insecurity due to local political
instability.
But Israel's dynamic scientific ecosystem is a hub of innovation shaping the
future. Despite global challenges and political shifts, the Israeli government's
unwavering support and industry resilience ensure a relentless pursuit of
groundbreaking solutions. In addition, companies have made the necessary
adjustments in order to continue delivering their service and products and
allow continuity of care at the highest level to customers - in Israel and
worldwide.
Optional messages:
Israel's scientific ecosystem is a global leader overcoming challenges,
propelling breakthroughs despite slowdowns.
Despite a temporary investment slowdown, our government support
and industry adaptability guarantee continued innovation and care
excellence worldwide
Israel's dynamic scientific hub thrives amid global shifts.
Despite global trends and local uncertainties, Israel's scientific pioneers
forge ahead.
Government backing, industry resilience, and adaptable companies
ensure our commitment to groundbreaking solutions remains
unshakable
-9-

10. Meir Pugatch, Chairman of the Research Committee, Health Council, and Initiative lead
Adriana Sisley, Director of Global Network, 8400 The Health Network
Amihood Singer, Ministry of Health MOH
Anat Arbel Shamir, Public Policy HSP & Roche for a Better Future Program Lead, Roche Israel
Anat Boehm-Cagan, Head of Regulation and Partnerships, Ministry of Health
Anya Eldan, CEO, Nuri Ventures Ltd. Former VP Israel Innovation Authority
Ariel Hammerman, Health Technology Assessment Director, Medison Pharma
Asher Shalmon, Chief Executive of the International Relations, Ministry of Health
Ayala Yogev, Head of Clinical Operations, Roche Israel
Calanit Key, Ombudswoman, Clalit Health Services
Carmil Azran, Director of Medical Technology Department, Maccabi Health Services
Daphne Morwitz, Co-Founder & CEO , 8400 The Health Network
Doron Shalit, General Manager, CSL Israel
Einav Zauber, Head of Rx and OTC Division, Trupharm
Galit Kopatz , General Manager, Novo Nordisk Israel
Guy Gorecki, Policy & Public Affairs Director, Pfizer Israel
Harella Halevy, Healthcare Communications consultant, lecturer and writer
Iris Adler, Health Tech Sector Lead at Start-Up Nation Central
Michal Roll, Co-Director Therapeutics and Regulatory Science, Faculty of Medicine, TA University
Miri Idan Malik, Business Unit Head, Sanofi Israel
Nathalie Bloch, Chief Innovation and the Future of Healthcare Officer
Nicky Nicu Liebermann, Community Division Consultant in Health Policy at Clalit Health Services
Orly Dror Azuriel, Founder and Director of the Israeli Association for Fighting A-T Disease and of
the Coalition of Rare Diseases in Israel
Orly Harel, CEO and Co-Founder of Serenus.AI
Rachel Nissanholtz Gannot, Associate Professor, Medical school Ariel University
Ronya Rubinstein, Digital Health and Femtech, ComNS, Public Policy HSP & Riche for a Better
Future Prigram Lead
Shira Oberlander, Strategic Accounts Manager and Goverment Affairs, Medtronic
Shomrat Shurtz, Deputy VP Growth Division, Senior Director, Business Development, Israel
Innovation Authority
Sigal Yosef, Head of LS, Innovation and R&D Incentives Center, EY
Tammy Altarac, Managing Director, MSD Israel
Tina Meerry Melusyan, General Manager Specialty Care & Country Lead Israel, Sanofi
Yael Gruenbaum-Cohen, Venture Parnter and Head of aMoon Alpha
Yael Ophir, Executive Director, HealthIL
Israel Life Science Hub Initiative - List of Partners
Thanks go to other people who helped to realize the project: Lior Shoham, Dana Gelbaum,
Carmit Ken-Dror and many others were helped behind the scenes.